End-of-day quote
Shenzhen S.E.
03:30:00 30/04/2024 am IST
|
5-day change
|
1st Jan Change
|
10.2
CNY
|
-0.49%
|
|
+12.09%
|
-23.25%
|
Fiscal Period: December |
2021
|
2022
|
2023
|
---|
Capitalization
1 |
13,910
|
7,854
|
5,323
|
Enterprise Value (EV)
1 |
13,203
|
7,433
|
5,323
|
P/E ratio
|
60.1
x
|
12.7
x
|
-37.6
x
|
Yield
|
0.86%
|
1.53%
|
-
|
Capitalization / Revenue
|
7.82
x
|
1.87
x
|
3.18
x
|
EV / Revenue
|
7.42
x
|
1.77
x
|
3.18
x
|
EV / EBITDA
|
39.4
x
|
6.6
x
|
70.9
x
|
EV / FCF
|
340
x
|
-19.6
x
|
-
|
FCF Yield
|
0.29%
|
-5.11%
|
-
|
Price to Book
|
8.89
x
|
3.81
x
|
-
|
Nbr of stocks (in thousands)
|
4,00,517
|
4,00,517
|
4,00,517
|
Reference price
2 |
34.73
|
19.61
|
13.29
|
Announcement Date
|
28/03/22
|
26/04/23
|
26/04/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
1,053
|
1,153
|
1,238
|
1,778
|
4,199
|
1,674
|
EBITDA
1 |
111.9
|
121.1
|
170.8
|
335
|
1,127
|
75.1
|
EBIT
1 |
92.12
|
106.5
|
156.9
|
294.1
|
1,069
|
25.89
|
Operating Margin
|
8.75%
|
9.23%
|
12.67%
|
16.54%
|
25.46%
|
1.55%
|
Earnings before Tax (EBT)
1 |
105.7
|
126.3
|
162.3
|
318
|
904.4
|
-153.2
|
Net income
1 |
73.39
|
92.24
|
110.4
|
203.8
|
617.3
|
-141.6
|
Net margin
|
6.97%
|
8%
|
8.91%
|
11.46%
|
14.7%
|
-8.46%
|
EPS
2 |
0.2082
|
0.2617
|
0.3132
|
0.5783
|
1.541
|
-0.3535
|
Free Cash Flow
1 |
49.02
|
-49.5
|
72.6
|
38.83
|
-379.9
|
-
|
FCF margin
|
4.66%
|
-4.29%
|
5.86%
|
2.18%
|
-9.05%
|
-
|
FCF Conversion (EBITDA)
|
43.8%
|
-
|
42.51%
|
11.59%
|
-
|
-
|
FCF Conversion (Net income)
|
66.8%
|
-
|
65.77%
|
19.05%
|
-
|
-
|
Dividend per Share
2 |
0.1800
|
0.1000
|
-
|
0.3000
|
0.3000
|
-
|
Announcement Date
|
18/11/20
|
18/11/20
|
21/05/21
|
28/03/22
|
26/04/23
|
26/04/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
483
|
485
|
533
|
707
|
421
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
49
|
-49.5
|
72.6
|
38.8
|
-380
|
-
|
ROE (net income / shareholders' equity)
|
6.47%
|
7.9%
|
10.9%
|
18.1%
|
37.8%
|
-
|
ROA (Net income/ Total Assets)
|
4.15%
|
4.68%
|
6.83%
|
10.3%
|
22.8%
|
-
|
Assets
1 |
1,767
|
1,969
|
1,616
|
1,983
|
2,703
|
-
|
Book Value Per Share
2 |
3.270
|
3.350
|
3.470
|
3.910
|
5.150
|
-
|
Cash Flow per Share
2 |
0.5800
|
0.7300
|
1.170
|
0.8800
|
1.660
|
-
|
Capex
1 |
73.3
|
39.5
|
44.5
|
119
|
230
|
399
|
Capex / Sales
|
6.97%
|
3.43%
|
3.6%
|
6.69%
|
5.48%
|
23.82%
|
Announcement Date
|
18/11/20
|
18/11/20
|
21/05/21
|
28/03/22
|
26/04/23
|
26/04/24
|
|
1st Jan change
|
Capi.
|
---|
| -23.25% | 564M | | -17.86% | 8.35B | | +39.49% | 3.58B | | -38.71% | 2.46B | | -8.06% | 2.47B | | -7.96% | 2.36B | | -13.97% | 1.78B | | -19.73% | 1.53B | | -40.78% | 1.21B | | +8.32% | 1.12B |
Medical & Diagnostic Laboratories
|